SEBI Constitutes Working Group to Review the Innovators Growth Platform Framework

The working group will examine whether current eligibility, listing and disclosure requirements remain fit for deep-tech, biotech, semiconductor, space and other research-intensive start-ups seeking public capital. For compliance teams, the near-term obligation is monitoring rather than remediation: no new filing or conduct requirements are announced in this press release. However, exchanges, merchant bankers, legal advisers and IPO-bound innovation companies should use the review period to reassess IGP listing readiness, governance and investor-protection safeguards.

Firms with start-up or growth-company pipelines should track any consultation or draft amendments and consider whether to engage in the policy process. The strategic implication is a possible widening of capital-market access for high-growth issuers, which could create advisory and transaction opportunities while reinforcing scrutiny of disclosure quality and investor safeguards.